Ceritinib is an inhibitor for ALK-positive, metastatic NSCLC. It’s a treatment. It works by focusing on the ALK signaling pathway.
This pathway is a big deal in how this cancer grows. You can get Ceritinib in 150 mg capsules. The dose for adults is 450 mg, taken every day with meals.
Each bottle has 70 capsules, so it’s good for 70 days on the recommended dose.
